Trianta Immunotherapies


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Trianta Immunotherapies was founded in late 2013 to exploit the therapeutic and commercial potential of innovative T cell-focused therapies developed by the team of Prof. Dolores Schendel at the Helmholtz Zentrum Munchen, in collaboration with Prof. Thomas Blankenstein at the Max Delbruck Centre for Molecular Medicine Berlin-Buch. The company is working on three platforms for the personalized treatment of various tumour types and stages, each one focused on T cells: Dendritic cell vaccines, clin...Show all

Trianta Immunotherapies was founded in late 2013 to exploit the therapeutic and commercial potential of innovative T cell-focused therapies developed by the team of Prof. Dolores Schendel at the Helmholtz Zentrum Munchen, in collaboration with Prof. ...Show all

Company (Acquired)

Phone: +49 (0)89 3187-1301

Fax:

Am Klopferspitz 19 a

Planegg-Martinsried, D-82152
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Trianta Immunotherapies $0M Jan 27, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Trianta Immunotherapies Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)